Management of Abnormal Pap Tests


2012 Pap Test Screening Recommendations

Journal article- 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

Unsatisfactory Cytology

Cytology Normal but EC/TZ Absent/Insufficient

Management of Women greater than or equal to Age 30, who are Cytology Negative, but HPV Positive

Management of Women with ASCUS on Cytology

Management of Women Ages 21 to 24 years with either ASCUS or LSIL

Management of Women with LSIL

Management of Pregnant Women with LSIL

Management of Women with ASC-H

Management of Women Ages 21 to 24 yrs with ASC-H and HSIL

Management of Women with HSIL

Initial Workup of Women with Atypical Glandular Cells (AGC)

Subsequent Management of Women with Atypical Glandular Cells (AGC)

Management of Women with No Lesion or Biopsy-confirmed Cervical Intraepithelial Neoplasia - Grade 1 (CIN1) Preceded by Lesser Abnormalities

Management of Women with No Lesion or Biopsy-confirmed Cervical Intraepithelial Neoplasia - Grade 1 (CIN1) Preceded by ASC-H or HSIL Cytology

Management of Women with No lesion or Biopsy-confirmed Cervical Intraepithelial Neoplasia - Grade 1 (CIN1) in Women Ages 21 to 24

Management of Women with Biopsy-confirmed Cervical Intraepithelial Neoplasia - Grade 2 and 3 (CIN2,3)

Management of Young Women with Biopsy-confirmed Cervical Intraepithelial Neoplasia - Grade 2,3 (CIN2,3) in Special Circumstances

Management of Women Diagnosed with Adenocarcinoma in-situ (AIS) during a Diagnostic Excisional Procedure